Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial

BACKGROUND: The Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 trial demonstrated a 39% reduction in HIV infection, with a 54% HIV reduction in women who used tenofovir gel consistently. A confirmatory trial is expected to report results in early 2015. In the interim, we hav...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Trials
Hoofdauteurs: Mansoor, Leila E, Abdool Karim, Quarraisha, Mngadi, Kathryn T, Dlamini, Sarah, Montague, Carl, Nkomonde, Nelisiwe, Mvandaba, Nomzamo, Baxter, Cheryl, Gengiah, Tanuja N, Samsunder, Natasha, Dawood, Halima, Grobler, Anneke, Frohlich, Janet A, Abdool Karim, Salim S
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2014
Onderwerpen:
Study Protocol
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4300828/
https://ncbi.nlm.nih.gov/pubmed/25527071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-496
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items